BVS Annual Total Liabilities
$589.79 M
-$370.63 M-38.59%
31 December 2023
Summary:
As of January 28, 2025, BVS annual total liabilities is $589.79 million, with the most recent change of -$370.63 million (-38.59%) on December 31, 2023. During the last 3 years, it has risen by +$239.49 million (+68.36%). BVS annual total liabilities is now -38.59% below its all-time high of $960.43 million, reached on December 31, 2022.BVS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVS Quarterly Total Liabilities
$582.66 M
-$20.45 M-3.39%
28 September 2024
Summary:
As of January 28, 2025, BVS quarterly total liabilities is $582.66 million, with the most recent change of -$20.45 million (-3.39%) on September 28, 2024. Over the past year, it has dropped by -$7.13 million (-1.21%). BVS quarterly total liabilities is now -42.81% below its all-time high of $1.02 billion, reached on September 1, 2022.BVS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVS Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -38.6% | -1.2% |
3 y3 years | +68.4% | -15.8% |
5 y5 years | +98.3% | -15.8% |
BVS Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -38.6% | at low | -42.8% | +1.0% |
5 y | 5-year | -38.6% | +80.5% | -42.8% | +78.3% |
alltime | all time | -38.6% | +133.2% | -42.8% | +94.2% |
Bioventus Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $582.66 M(-3.4%) |
June 2024 | - | $603.11 M(+4.6%) |
Mar 2024 | - | $576.81 M(-2.2%) |
Dec 2023 | $589.79 M(-38.6%) | $589.79 M(+0.9%) |
Sept 2023 | - | $584.65 M(-3.1%) |
June 2023 | - | $603.62 M(-6.7%) |
Mar 2023 | - | $647.04 M(-32.6%) |
Dec 2022 | $960.43 M(+38.8%) | $960.43 M(-5.7%) |
Sept 2022 | - | $1.02 B(+48.0%) |
June 2022 | - | $688.59 M(+2.0%) |
Mar 2022 | - | $675.22 M(-2.4%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $692.07 M(+97.6%) | $692.07 M(+63.1%) |
Sept 2021 | - | $424.29 M(-0.7%) |
June 2021 | - | $427.27 M(+1.1%) |
Mar 2021 | - | $422.79 M(+20.7%) |
Dec 2020 | $350.31 M(+7.2%) | $350.31 M(+4.9%) |
Sept 2020 | - | $333.94 M(+2.2%) |
Dec 2019 | $326.79 M(+9.9%) | $326.79 M(+8.9%) |
Dec 2018 | $297.46 M(+0.8%) | - |
Mar 2016 | - | $299.96 M |
Dec 2015 | $295.01 M(+16.6%) | - |
Dec 2014 | $252.93 M | - |
FAQ
- What is Bioventus annual total liabilities?
- What is the all time high annual total liabilities for Bioventus?
- What is Bioventus annual total liabilities year-on-year change?
- What is Bioventus quarterly total liabilities?
- What is the all time high quarterly total liabilities for Bioventus?
- What is Bioventus quarterly total liabilities year-on-year change?
What is Bioventus annual total liabilities?
The current annual total liabilities of BVS is $589.79 M
What is the all time high annual total liabilities for Bioventus?
Bioventus all-time high annual total liabilities is $960.43 M
What is Bioventus annual total liabilities year-on-year change?
Over the past year, BVS annual total liabilities has changed by -$370.63 M (-38.59%)
What is Bioventus quarterly total liabilities?
The current quarterly total liabilities of BVS is $582.66 M
What is the all time high quarterly total liabilities for Bioventus?
Bioventus all-time high quarterly total liabilities is $1.02 B
What is Bioventus quarterly total liabilities year-on-year change?
Over the past year, BVS quarterly total liabilities has changed by -$7.13 M (-1.21%)